Coherent, Inc.
COHR is executing well into an AI optics upcycle, but execution strength is already more than priced in at 165.56x P/E and 8.93x sales, leaving little room for anything short of near-perfect delivery.
The argument against COHR at $331.84 is simple: the company is winning in AI optics, but the stock already prices in a much more mature earnings and cash flow profile than the one on the page today. Revenue is real. Q3 hit a record $1.8B, up 21% y/y, and Q4 guidance of $1.91B-$2.05B with $1.52-$1.72 of non-GAAP EPS points to another step up. Management also has unusually strong visibility, with backlog stretching into calendar 2028 and LTAs to the end of the decade. That is the bull case, and it is not fictional.
The problem is what investors are paying for that growth. At 165.56x P/E and 8.93x sales, COHR trades at a massive premium to peers at 38.4x P/E and 3.6x sales. That premium might be defensible if the business already had high-quality profits and cash generation. It does not. FY2025 operating margin was only 8.3%, net margin 1.2%, and free cash flow - $0.4B. Even in the latest quarter, where gross margin improved to 39.6%, EBITDA margin fell to 10.2%, down 1,000 bps sequentially. In other words, investors are valuing COHR like a scarce AI infrastructure winner while the financials still look like a company in the middle of an expensive build-out.
The second issue is that the stock has already absorbed a lot of the good news. Shares remain 26.9% above the 200-day average despite being 24.6% below the high, which means this is not a hated name offering deep downside protection. It is a momentum winner that recently corrected. Ahead of earnings in 2 days, the burden is on management not just to beat numbers, but to prove that capex, rising opex, and supply constraints will convert into materially better cash earnings in fiscal 2027.
What would change the call is straightforward. A meaningful improvement in cash generation, evidence that AI optics margins can hold near or above 40% gross margin while EBITDA margin recovers, and a valuation reset closer to the engine's $131.99 base case or at least toward peer-relative levels would make the stock more interesting. Until then, the business can keep getting better while the stock still goes lower.
COHR executes near flawlessly on indium phosphide, 6-inch, and OCS ramps, pushing fiscal 2027 earnings materially above current expectations and sustaining AI scarcity pricing.
Revenue growth stays solid, but valuation compresses materially as investors focus on cash flow and peer-relative multiples rather than backlog alone.
AI demand stays healthy but margin conversion disappoints, capex remains elevated, and the stock de-rates closer to high-growth hardware comps.
Quant call (SELL) diverges from analyst consensus (Strong Buy: 6 buy / 1 hold / 0 sell) — resolve explicitly.
The four most dangerous words in investing are: 'this time it's different.'
Forward earnings are improving fast, with Q4 non-GAAP EPS guided to $1.52-$1.72 and management calling for fiscal '27 growth to exceed fiscal '26, but the stock is already trading on a future where AI optics capacity converts into durable high margins and solid free cash flow. The moat is stronger today than it was two years ago because indium phosphide, 6-inch manufacturing, transceiver qualification, and optical switching all create real barriers, yet over 3-5 years durability depends on whether COHR keeps process leadership as customers and rivals push harder into integrated optics and cost-down cycles. AI is a major tailwind because optical bandwidth demand is structural, not cyclical, but this is an advantaged supplier, not a software-like winner, so returns are still capped by manufacturing intensity, customer concentration, and pricing discipline. At 165.56x P/E, the market is paying for a far cleaner future than the current 8.3% operating margin and negative FY2025 FCF support.
- Valuation is extreme at 165.56x P/E and 8.93x P/S, versus peer averages of 38.4x P/E and 3.6x P/S.
- AI-driven growth is real, with Q3 revenue up 21% y/y and Q4 revenue guided to $1.91B-$2.05B, while management says fiscal '27 growth rate should exceed fiscal '26.
- Cash flow and margin quality lag the stock price, with FY2025 FCF at -$0.4B, FY2025 operating margin at 8.3%, and Q3 EBITDA margin at 10.2%, down 1,000 bps sequentially.
- Record $1.8B Q3 revenue, up 7% sequentially and 21% y/y, was driven by AI data center and communications demand, showing the core franchise is gaining share in the right end markets.
- Management guided Q4 revenue to $1.91B-$2.05B and non-GAAP EPS to $1.52-$1.72, and explicitly said, "We expect strong sequential revenue growth in our June quarter, and we continue to expect fiscal '27 growth rate to exceed our fiscal '26 growth rate."
- Execution on capacity has improved: indium phosphide output doubling is now expected one quarter earlier, the 6-inch ramp is contributing first transceiver shipments, and the OCS bottleneck has been resolved across 2 facilities.
- Balance-sheet strain has eased materially on the latest call, with cash at $3.0B and management citing debt leverage down to 0.5x, reducing the odds that the AI build-out is funded from a position of weakness.
- The market cap of $60.3B sits on a business that generated only $5.8B FY2025 revenue, 1.2% net margin, and - $0.4B FCF, an unusually rich valuation for a company still proving the quality of its earnings.
- Profit conversion remains mixed: Q3 gross margin was 39.6%, but Q3 EBITDA margin fell to 10.2%, down 410 bps y/y and 1,000 bps vs Q2, as growth required much heavier spending.
- Supply remains a gating factor, as management still calls out industry-wide indium phosphide constraints, which means backlog into 2028 is not the same thing as revenue that can be shipped on time.
- Some end markets are still weak. Management said industrial revenue declined modestly both sequentially and y/y, and the earlier 2024 call warned telecom softness could persist through at least 6-12 months, underscoring that not all of the portfolio is riding the AI wave.
| Metric | Value | Context |
|---|---|---|
| Current price | $331.84 | Reference price for target comparison |
| Quant price target | $131.99 | -60.2% vs current, Low confidence, basis: earnings_growth_blend |
| FY2025 revenue | $5.8B | +18.9% YoY |
| FY2025 EPS | $-0.52 | -122.8% YoY, despite strong recent non-GAAP EPS beats |
| FY2025 operating margin | 8.3% | Improved from 2.6% in prior FY, still modest for valuation |
| FY2025 net margin | 1.2% | Very thin relative to market cap and sales multiple |
| Valuation | 165.56x P/E | 8.93x P/S | 5.52x P/B | Versus peer avg 38.4x P/E and 3.6x P/S |
| Leverage | 0.32 Debt/Equity | 3.10 Debt/EBITDA | Balance sheet acceptable, though latest call cited leverage down to 0.5x |
| Liquidity | 3.05 current ratio | Healthy near-term balance-sheet flexibility |
| Free cash flow | $-0.4B | FY2025, despite AI demand strength |
| Latest quarter and guide | Q3 revenue $1.81B, Q3 EBITDA $0.18B, Q4 EPS guide $1.52-$1.72 | Q3 EBITDA margin 10.2%; Q4 revenue guide $1.91B-$2.05B |
| Price action | -24.6% vs 52-week high | +26.9% vs 200-day avg | 3M -18.02%, setup still elevated despite pullback |
The biggest risk to the SELL is that AI optics demand stays supply-constrained and COHR converts its 2028 backlog visibility into sustained 40%+ gross margin earnings power much faster than the current cash flow profile implies.
The next catalyst is Q4 earnings on August 12, 2026, especially whether revenue lands near the top of the $1.91B-$2.05B guide and whether margin and capex commentary supports fiscal 2027 earnings power rather than just backlog enthusiasm.
Ownership is crowded, with the top 3 institutions holding 71.3% and major holders including Fidelity, BlackRock, Vanguard, State Street, and Nvidia, which helps sponsorship but can amplify rotations when sentiment cools. Short interest is only 4.65%, or 8.69M shares, with 1.4 days-to-cover, so there is not much embedded squeeze fuel. Options positioning is mildly supportive, with positive GEX and a zero-gamma level at $311.8, but that is more a near-term trading stabilizer than a fundamental reason to own a stock at this valuation.
Current growth engine, with Q3 revenue up 21% y/y overall and management attributing demand to AI data center and communications.
Management said revenue declined modestly sequentially and year-over-year, making it a drag versus AI-facing categories.
6-inch ramp drove first transceiver shipments in Q3 and the OCS bottleneck resolved, so both should be incremental growth contributors into fiscal 2027.
No geographic split was provided in the supplied data.
Q4 guide implies accelerating growth, backed by record backlog and earlier capacity gains.
Management's execution since the 2024 Q4 call has been better than promised. Two years ago, management guided Q1 FY25 revenue to $1.27B-$1.35B, gross margin to 36%-38%, and EPS to $0.53-$0.59, while saying FY25 would be a "solid growth year" despite telecom and industrial softness. What followed was a clean beat pattern across 8 straight quarters, from +1.7% to +37.7% versus EPS estimates, and FY2025 revenue reached $5.8B, up 18.9%, with operating margin improving to 8.3% from 2.6%. The company also appears to have advanced product and capacity timelines, with 1.6T progressing from samples in 2024 to first transceiver shipments and management now saying indium phosphide capacity doubling will come one quarter earlier than planned. The blemish is cash and margin conversion: gross margin improved from 37.2% in the 2024 Q4 call setup to 39.6% in 2026 Q3, but Q3 EBITDA margin fell to 10.2%, and FY2025 FCF was -$0.4B, so execution is credible on growth and operations, less proven on translating that into durable economic returns.
We expect strong sequential revenue growth in our June quarter, and we continue to expect fiscal '27 growth rate to exceed our fiscal '26 growth rate.
We expect revenue to be between $1.91 billion and $2.05 billion. We expect EPS of between $1.52 and $1.72 on a non-GAAP basis.
This quarter, we experienced another step function increase in our order book, driving our backlog to a record level. Customer demand remains exceptionally strong with no signs of attenuation, and our visibility continues to extend further into the future with orders now reaching into calendar 2028 and customer LTAs extending to the end of the decade.
We remain on track to achieve our goal of doubling internal indium phosphide output capacity by the end of this calendar year. And based on current execution, we now expect to reach that milestone 1 quarter earlier than originally planned.
Third quarter revenue was a record $1.8 billion, up 7% sequentially from the second quarter, and up 21% year-over-year, driven by growth in AI data center and communications demand.
COHR's moat sits in compound semiconductor manufacturing, qualification-heavy optical components, and the hard-to-replicate process know-how around indium phosphide, 6-inch wafer ramps, and high-speed transceivers. That moat is real because customers cannot casually swap suppliers in mission-critical optical links, and record orders extending into 2028 suggest sticky design wins. Durability is moderate rather than exceptional because this is still a capex-heavy hardware market where leadership can narrow if competitors match yields, capacity, or integration over the next 3-5 years.
Capital allocation is currently tilted toward expansion, not shareholder return. Q3 capex was $290M and management said capex would rise again in Q4, while the deep-dive data shows $0.0B buybacks and $0.0B dividends, which is sensible given the need to fund AI datacom and communications capacity. The concern is discipline: FY2025 FCF was -$0.4B, so the company is asking investors to underwrite heavy investment today for future margin and cash returns that still need to show up cleanly.
COHR is a better business than it was two years ago, but the stock remains a SELL because $331.84 prices in too much of that improvement already. The AI optics story is real, management execution has been good, and demand visibility is unusually long, but investors are paying 165.56x earnings and 8.93x sales for a company that still posted - $0.4B FCF in FY2025. That mismatch matters more than the bullish narrative going into earnings. The call would change on a much lower entry price, or on clear evidence that fiscal 2027 converts backlog into sustainably stronger EBITDA and free cash flow, not just more capex-funded growth.
≣ Full research note tap to expand
Executive Summary
SELL, Medium conviction. COHR rates a SELL at Medium conviction. The business is clearly improving, with Q3 revenue of $1.8B, Q4 EPS guide of $1.52-$1.72, record backlog into calendar 2028, and a visible AI datacom ramp, but the stock at $331.84 already discounts a far stronger margin and cash flow profile than the company has yet delivered. With the shares still 26.9% above the 200-day average and only 24.6% below the $440 high after a huge move, the setup is skewed against new buyers ahead of earnings.
Investment Thesis
The argument against COHR at $331.84 is simple: the company is winning in AI optics, but the stock already prices in a much more mature earnings and cash flow profile than the one on the page today. Revenue is real. Q3 hit a record $1.8B, up 21% y/y, and Q4 guidance of $1.91B-$2.05B with $1.52-$1.72 of non-GAAP EPS points to another step up. Management also has unusually strong visibility, with backlog stretching into calendar 2028 and LTAs to the end of the decade. That is the bull case, and it is not fictional.
The problem is what investors are paying for that growth. At 165.56x P/E and 8.93x sales, COHR trades at a massive premium to peers at 38.4x P/E and 3.6x sales. That premium might be defensible if the business already had high-quality profits and cash generation. It does not. FY2025 operating margin was only 8.3%, net margin 1.2%, and free cash flow - $0.4B. Even in the latest quarter, where gross margin improved to 39.6%, EBITDA margin fell to 10.2%, down 1,000 bps sequentially. In other words, investors are valuing COHR like a scarce AI infrastructure winner while the financials still look like a company in the middle of an expensive build-out.
The second issue is that the stock has already absorbed a lot of the good news. Shares remain 26.9% above the 200-day average despite being 24.6% below the high, which means this is not a hated name offering deep downside protection. It is a momentum winner that recently corrected. Ahead of earnings in 2 days, the burden is on management not just to beat numbers, but to prove that capex, rising opex, and supply constraints will convert into materially better cash earnings in fiscal 2027.
What would change the call is straightforward. A meaningful improvement in cash generation, evidence that AI optics margins can hold near or above 40% gross margin while EBITDA margin recovers, and a valuation reset closer to the engine's $131.99 base case or at least toward peer-relative levels would make the stock more interesting. Until then, the business can keep getting better while the stock still goes lower.
Key Metrics
| Metric | Value | Context | ||
|---|---|---|---|---|
| Current price | $331.84 | Reference price for target comparison | ||
| Quant price target | $131.99 | -60.2% vs current, Low confidence, basis: earnings_growth_blend | ||
| FY2025 revenue | $5.8B | +18.9% YoY | ||
| FY2025 EPS | $-0.52 | -122.8% YoY, despite strong recent non-GAAP EPS beats | ||
| FY2025 operating margin | 8.3% | Improved from 2.6% in prior FY, still modest for valuation | ||
| FY2025 net margin | 1.2% | Very thin relative to market cap and sales multiple | ||
| Valuation | 165.56x P/E | 8.93x P/S | 5.52x P/B | Versus peer avg 38.4x P/E and 3.6x P/S |
| Leverage | 0.32 Debt/Equity | 3.10 Debt/EBITDA | Balance sheet acceptable, though latest call cited leverage down to 0.5x | |
| Liquidity | 3.05 current ratio | Healthy near-term balance-sheet flexibility | ||
| Free cash flow | $-0.4B | FY2025, despite AI demand strength | ||
| Latest quarter and guide | Q3 revenue $1.81B, Q3 EBITDA $0.18B, Q4 EPS guide $1.52-$1.72 | Q3 EBITDA margin 10.2%; Q4 revenue guide $1.91B-$2.05B | ||
| Price action | -24.6% vs 52-week high | +26.9% vs 200-day avg | 3M -18.02%, setup still elevated despite pullback |
Financial Strength
The balance sheet is no longer the core issue. Liquidity looks fine at a 3.05 current ratio, debt is manageable at 0.32 debt/equity, and management said the latest quarter ended with $3.0B cash and leverage down to 0.5x, a much better place than investors feared during the integration and build-out phase. The issue is economic quality, not solvency: the company is funding a large capacity ramp with negative FY2025 free cash flow and rising capex, while margin improvement below gross profit has not yet kept pace with the valuation. COHR can afford the spend, but the market is already pricing as if that spend has produced cleaner, more durable returns than it actually has.
Competitive Position
COHR's moat sits in compound semiconductor manufacturing, qualification-heavy optical components, and the hard-to-replicate process know-how around indium phosphide, 6-inch wafer ramps, and high-speed transceivers. That moat is real because customers cannot casually swap suppliers in mission-critical optical links, and record orders extending into 2028 suggest sticky design wins. Durability is moderate rather than exceptional because this is still a capex-heavy hardware market where leadership can narrow if competitors match yields, capacity, or integration over the next 3-5 years.
Management & Guidance
Current guidance is strong and directionally credible. Management guided Q4 FY26 revenue to $1.91B-$2.05B, non-GAAP gross margin to 39%-41%, opex to $360M-$380M, and non-GAAP EPS to $1.52-$1.72, while saying backlog now reaches into calendar 2028 and fiscal 2027 growth should exceed fiscal 2026. That optimism carries weight because the company has beaten EPS estimates for 8 consecutive quarters, including +11.5%, +7.5%, +5.8%, +6.6%, and +0.7% in the last five. The limitation is that guidance still leans on heavy capex and rising opex, so the key question is not whether COHR can hit near-term revenue and EPS, but whether it can do so while improving cash conversion enough to justify the current stock price.
Segment Analysis
- AI datacom and communications (Not disclosed): Current growth engine, with Q3 revenue up 21% y/y overall and management attributing demand to AI data center and communications.
- Industrial (Not disclosed): Management said revenue declined modestly sequentially and year-over-year, making it a drag versus AI-facing categories.
- Optical switching and transceivers (Not disclosed): 6-inch ramp drove first transceiver shipments in Q3 and the OCS bottleneck resolved, so both should be incremental growth contributors into fiscal 2027.
- Geography (Not disclosed): No geographic split was provided in the supplied data.
Capital Allocation
Capital allocation is currently tilted toward expansion, not shareholder return. Q3 capex was $290M and management said capex would rise again in Q4, while the deep-dive data shows $0.0B buybacks and $0.0B dividends, which is sensible given the need to fund AI datacom and communications capacity. The concern is discipline: FY2025 FCF was -$0.4B, so the company is asking investors to underwrite heavy investment today for future margin and cash returns that still need to show up cleanly.
Management Execution & Track Record
Management's execution since the 2024 Q4 call has been better than promised. Two years ago, management guided Q1 FY25 revenue to $1.27B-$1.35B, gross margin to 36%-38%, and EPS to $0.53-$0.59, while saying FY25 would be a "solid growth year" despite telecom and industrial softness. What followed was a clean beat pattern across 8 straight quarters, from +1.7% to +37.7% versus EPS estimates, and FY2025 revenue reached $5.8B, up 18.9%, with operating margin improving to 8.3% from 2.6%. The company also appears to have advanced product and capacity timelines, with 1.6T progressing from samples in 2024 to first transceiver shipments and management now saying indium phosphide capacity doubling will come one quarter earlier than planned. The blemish is cash and margin conversion: gross margin improved from 37.2% in the 2024 Q4 call setup to 39.6% in 2026 Q3, but Q3 EBITDA margin fell to 10.2%, and FY2025 FCF was -$0.4B, so execution is credible on growth and operations, less proven on translating that into durable economic returns.
Positioning & Flows
Ownership is crowded, with the top 3 institutions holding 71.3% and major holders including Fidelity, BlackRock, Vanguard, State Street, and Nvidia, which helps sponsorship but can amplify rotations when sentiment cools. Short interest is only 4.65%, or 8.69M shares, with 1.4 days-to-cover, so there is not much embedded squeeze fuel. Options positioning is mildly supportive, with positive GEX and a zero-gamma level at $311.8, but that is more a near-term trading stabilizer than a fundamental reason to own a stock at this valuation.
Bull Case
- Record $1.8B Q3 revenue, up 7% sequentially and 21% y/y, was driven by AI data center and communications demand, showing the core franchise is gaining share in the right end markets.
- Management guided Q4 revenue to $1.91B-$2.05B and non-GAAP EPS to $1.52-$1.72, and explicitly said, "We expect strong sequential revenue growth in our June quarter, and we continue to expect fiscal '27 growth rate to exceed our fiscal '26 growth rate."
- Execution on capacity has improved: indium phosphide output doubling is now expected one quarter earlier, the 6-inch ramp is contributing first transceiver shipments, and the OCS bottleneck has been resolved across 2 facilities.
- Balance-sheet strain has eased materially on the latest call, with cash at $3.0B and management citing debt leverage down to 0.5x, reducing the odds that the AI build-out is funded from a position of weakness.
Bear Case
- The market cap of $60.3B sits on a business that generated only $5.8B FY2025 revenue, 1.2% net margin, and - $0.4B FCF, an unusually rich valuation for a company still proving the quality of its earnings.
- Profit conversion remains mixed: Q3 gross margin was 39.6%, but Q3 EBITDA margin fell to 10.2%, down 410 bps y/y and 1,000 bps vs Q2, as growth required much heavier spending.
- Supply remains a gating factor, as management still calls out industry-wide indium phosphide constraints, which means backlog into 2028 is not the same thing as revenue that can be shipped on time.
- Some end markets are still weak. Management said industrial revenue declined modestly both sequentially and y/y, and the earlier 2024 call warned telecom softness could persist through at least 6-12 months, underscoring that not all of the portfolio is riding the AI wave.
Valuation & Price Target
Engine price target $131.99 (-60.2% vs current), Low confidence.
- P/E Multiple: $63.31 (13% weight)
- PEG (growth-adjusted): $64.92 (20% weight)
- P/S Multiple: $113.36 (20% weight)
- Quality-adjusted: $291.49 (20% weight)
- DCF: $3.69 (4% weight)
This rating aligns with the quant baseline SELL, though with Medium rather than low conviction because the operating story is stronger than a pure screen captures. The engine's $131.99 target is directionally supported by the valuation stack: P/E Multiple $63.31, PEG $64.92, P/S Multiple $113.36, Quality-adjusted $291.49, and DCF $3.69, which together say the current $331.84 price demands heroic assumptions. The case against ownership is not broken demand, it is that a business with 8.3% FY2025 operating margin, 1.2% net margin, and - $0.4B FCF trades at 165.56x earnings and 8.93x sales despite peer averages near 38.4x P/E and 3.6x P/S. Sell-side consensus is Strong Buy from 7 firms, but that is low-signal context here because the disagreement is best resolved by valuation versus delivered economics, not by tallying opinions.
Risk Assessment
Risk score 57/100 (Moderate). The biggest risk to the SELL is that AI optics demand stays supply-constrained and COHR converts its 2028 backlog visibility into sustained 40%+ gross margin earnings power much faster than the current cash flow profile implies.
The Bottom Line
COHR is a better business than it was two years ago, but the stock remains a SELL because $331.84 prices in too much of that improvement already. The AI optics story is real, management execution has been good, and demand visibility is unusually long, but investors are paying 165.56x earnings and 8.93x sales for a company that still posted - $0.4B FCF in FY2025. That mismatch matters more than the bullish narrative going into earnings. The call would change on a much lower entry price, or on clear evidence that fiscal 2027 converts backlog into sustainably stronger EBITDA and free cash flow, not just more capex-funded growth.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr